FDA Warns About Serious Side-Effects With Weightloss Drugs
From DeFranco News Clips · · 1 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.
If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.
Not rated yet
Description
The FDA just told Novo Nordisk and Eli Lilly to update warning labels on their GLP-1 and Trizepatide medications for weight loss and diabetes. It comes after credible reports of sudden blindness from a rare condition. —————————— Edited by: Christian Meeks Writing: Brian Espinoza, Philip DeFranco ———————————— #PhilipDeFranco #GLP1 #Fitness